TriSalus Life Sciences, Inc. (TLSI): Gross Profit

Annual figures by period end, from SEC filings.

$38.19M
Year ended 2025-12-31
$38.67M
Trailing 12 months to 2026-06-30
+55.6%
3-year compound annual growth
2022-12-31: $10.14M2023-12-31: $15.91M2024-12-31: $25.33M2025-12-31: $38.19M$38.19M
2022-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$38.19M+50.8%2026-03-05, From 2025-01-01
2024-12-31$25.33M+59.2%2026-03-05, From 2024-01-01
2023-12-31$15.91M+56.9%2025-05-30, From 2023-01-01
2022-12-31$10.14Mn/a2024-04-11, From 2022-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
TriSalus Life Sciences, Inc. (TLSI)2025-12-31$38.19M+50.8%
SANUWAVE Health, Inc. (SNWV)2025-12-31$33.97M+38.4%
Shoulder Innovations, Inc. (SI)2025-12-31$36.20M+48.7%
SS Innovations International, Inc. (SSII)2025-12-31$19.54M+131.2%
KORU Medical Systems, Inc. (KRMD)2025-12-31$25.60M+20.0%
Carlsmed, Inc. (CARL)2025-12-31$38.04M+89.7%
Interpace Biosciences, Inc. (IDXG)2025-12-31$24.13M-19.4%
Apyx Medical Corp (APYX)2025-12-31$33.04M+12.5%
Utah Medical Products Inc (UTMD)2025-12-31$22.00M-8.9%

Compare TLSI, SNWV, SI, SSII side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗